Cipla moves up on reporting marginal rise in Q3 consolidated net profit

Cipla

Cipla is currently trading at Rs. 911.15, up by 7.05 points or 0.78% from its previous closing of Rs. 904.10 on the BSE. The scrip opened at Rs. 904.00 and has touched a high and low of Rs. 923.55 and Rs. 887.65 respectively. So far 91680 shares were traded on the counter. The BSE group … Read more

Cipla’s arm completes acquisition of stake in Wellthy Therapeutics

Cipla’s wholly owned subsidiary — Goldencross Pharma has completed the closing of Wellthy Therapeutics, transaction representing an acquisition of 11.71% stake in Wellthy on fully diluted basis on March 08, 2019. Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio … Read more